Lexaria Bioscience (LEXX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LEXX Annual Balance Sheets →
The table below presents a historical view of Lexaria Bioscience's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(May 31 2026)
(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Assets
Cash & cash equivalent3.50
Short-term Investments, Total0.14
Other Short-term Investments AS0.00
Cash & Short-term Investments3.00
Accounts receivable0.11
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.40
Total Current Assets4.06
Equipment/Property/Plant Net0.23
Intangible Assets0.34
Long-term investments0.06
Other Assets, Noncurrent0.08
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents5.13
Total Assets4.78
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.35
Accrued Liabilities, Current0.35
Other Liabilities, Current0.00
Total Current Liabilities0.38
Total Long-term Debt0.00
Other liabilities, Noncurrent0.05
Finance Lease Liability Current0.03
Operating Lease Liability Noncurrent0.06
Total Liabilities0.44
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock73.26
Retained Earnings / Accumulated Deficit0.00
Accumulated Other Comprehensive Income-0.05
Other Equity-0.05
Common Stockholder's Equity5.13
Non-controlling interests & other-0.39
Total Stockholder's Equity4.74
Liabilities & Stockholder's Equity4.78
4 historic quarters locked

Sign in to unlock the full Lexaria Bioscience balance sheet history.

About Lexaria Bioscience Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260531)
  • Filed with the SEC: July 13, 2026
  • Source: lxrp_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-001166

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.